Globally, breast cancer is the most frequently diagnosed cancer and is the leading cause of cancer-related death in women.
1 In Japan, breast cancer is also the leading cancer in women, with breast cancer incidence rates peaking among women aged 45 to 49 years.
2 Mammography is the only screening modality that has been shown to be associated with reduced deaths caused by breast cancer. However, the sensitivity of mammography is variable and ranges from as high as 80% to 98% in women with fatty breast tissue to as low as 30% to 48% in women with dense breast tissue.
3,4 Because of the limitations of mammography and increase in breast cancer awareness, a few study groups have investigated the performance characteristics of supplementary screening tools, including breast ultrasonography, tomosynthesis, and magnetic resonance imaging.
5-8